All Articles

Lung cancer is the most common type of cancer in the United States.

Maintenance therapy has begun to emerge as a treatment standard for patients with non–small cell lung cancer (NSCLC) whose disease has not progressed after 4 to 6 cycles of frontline chemotherapy.

Improving outcomes for patients with non– small cell lung cancer (NSCLC) is particularly relevant because NSCLC accounts for 85% of all cases of lung cancer.

Significant advances in treating non–small cell lung cancer (NSCLC) have been made over the past 10 years; nevertheless, survival im provement in this disease pales compared with many other solid tumors. Because maintenance chemotherapy offers improved survival in NSCLC, patients and doctors are justifiably excited.

In the first year after a breast cancer diagnosis, women typically experience significant deterioration in their overall quality of life (QOL), but a program that connects new patients with breast cancer survivors following diagnosis seems to halt the decline.

I am thrilled to serve as Editor-in-Chief for the Journal of Oncology Navigation & Survivorship.

A self-administered questionnaire was distributed to a convenience sample of cancer survivors (N = 237) attending an annual cancer survivors’ day organized by a community cancer center.

With 11.7 million cancer survivors in the United States, the role of navigation in survivorship is growing. As our population ages, navigators will need to focus on the specific needs of the older and elderly patients they navigate through survivorship care.

Patient care navigation at the Billings Clinic Cancer Center spans the continuum of care from outreach efforts targeted at early detection through survivorship care planning.

Patient navigation and care coordination have been a focus in healthcare for several years because of the fragmentation that commonly occurs among access, diagnosis, and treatment.